Israel Discount Bank of New York’s West Pharmaceutical WST Stock Holding History

Israel Discount Bank of New York’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-830	Closed	-$82K	–	448
2018 Q2	$82K	Sell	830 -10	-1%	-$921	0.05%	158
2018 Q1	$74K	Hold	840	–	–	0.05%	188
2017 Q4	$83K	Sell	840 -25	-3%	-$2.45K	0.06%	159
2017 Q3	$83K	Hold	865	–	–	0.06%	165
2017 Q2	$82K	Sell	865 -125	-13%	-$11.5K	0.07%	170
2017 Q1	$81K	Sell	990 -25	-2%	-$2.09K	0.07%	156
2016 Q4	$86K	Buy	+1,015	New	+$79.8K	0.08%	156

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Israel Discount Bank of New York's WST Position: Q3 2018 in Review

Israel Discount Bank of New York sold out of West Pharmaceutical (WST) in Q3 2018, closing a stake of 830 shares — an estimated $82K sold.

Israel Discount Bank of New York first reported a position in WST in Q4 2016 and held it in 7 quarters. The position peaked at $86K in Q4 2016. 355 funds tracked by Wall St. Rank hold WST as of Q3 2018.

Israel Discount Bank of New York reported no remaining West Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Israel Discount Bank of New York sold 830 West Pharmaceutical shares in Q3 2018, an estimated $82K.
Israel Discount Bank of New York first reported a position in West Pharmaceutical in Q4 2016 and held it in 7 quarters.
Israel Discount Bank of New York's West Pharmaceutical position peaked at $86K in Q4 2016.
355 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2018.

Based on Israel Discount Bank of New York's 13F filing for Q3 2018, filed 14 Nov 2018.